Clinical Trial Update: Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ferumoxytol-enhanced MRI for detecting lymph node involvement in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ferumoxytol (Feraheme) (ferumoxytol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED